D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ATRA holding history
Atara Biotherapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ATRA overviewAll 13F holders of ATRAFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −1,033,992−100.0% | Sold out | Holders |
| Q4 2023 | 1,033,992 | $530.2K | <0.1% | −2,876,424−73.6% | Reduced | Holders |
| Q3 2023 | 3,910,416 | $5.79M | <0.1% | −438,912−10.1% | Reduced | Holders |
| Q2 2023 | 4,349,328 | $7.00M | <0.1% | +119,521+2.8% | Added | Holders |
| Q1 2023 | 4,229,807 | $12.3M | <0.1% | +697,807+19.8% | Added | Holders |
| Q4 2022 | 3,532,000 | $11.6M | <0.1% | +812,100+29.9% | Added | Holders |
| Q3 2022 | 2,719,900 | $10.3M | <0.1% | +2,051,695+307.0% | Added | Holders |
| Q2 2022 | 668,205 | $5.21M | <0.1% | +5,246+0.8% | Added | Holders |
| Q1 2022 | 662,959 | $6.16M | <0.1% | −256,442−27.9% | Reduced | Holders |
| Q4 2021 | 919,401 | $14.5M | <0.1% | +87,494+10.5% | Added | Holders |
| Q3 2021 | 831,907 | $14.9M | <0.1% | +13,376+1.6% | Added | Holders |
| Q2 2021 | 818,531 | $12.7M | <0.1% | +135,474+19.8% | Added | Holders |
| Q1 2021 | 683,057 | $9.81M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.